King’s Dogged Pursuit of Alpharma Comes Up Aces
This article was originally published in The Pink Sheet Daily
Executive Summary
The combined specialty pharma company to be a leader in abuse-resistant pain meds.
You may also be interested in...
Norway’s Xellia Pharma Acquired By Novo A/S In $700 Million Buyout
3i sells Nordic antibacterial manufacturer Xellia Pharmaceuticals, which has plans to develop novel antibiotics, new formulations and new bulk generics.
Chew On This: FDA OK's King's Tamper-Resistant Morphine, Embeda
Embeda to launch in September backed by 610 sales reps, Chief Commercial Officer Andrzejewski says.
Chew On This: FDA OK's King's Tamper-Resistant Morphine, Embeda
Embeda to launch in September backed by 610 sales reps, Chief Commercial Officer Andrzejewski says.